Article Text

other Versions

PDF
Repair of erosions occurs almost exclusively in damaged joints without swelling
  1. Cédric Lukas1,*,
  2. Désirée van der Heijde2,
  3. Saeed Fatenejad3,
  4. Robert Landewé4
  1. 1 Lapeyronie Hospital Montpellier, France;
  2. 2 Leiden University Medical Center, Netherlands;
  3. 3 Wyeth Research, United States;
  4. 4 University of Maastricht, Netherlands
  1. Correspondence to: cedric lukas, University Maastricht and CAPHRI Institute, P.O. Box 5800, Maastricht, 6202 AZ, Netherlands; cedriclukas{at}voila.fr

Abstract

Objective: Negative radiographic change scores obtained under blinded time-sequence conditions suggest that repair of joints may indeed occur. It is likely that - C if it truly exists - C repair would be preferentially seen in clinically inactive joints from patients treated with drugs with well known structural efficacy.

Patients and methods: Radiographs from patients of the TEMPO trial were scored twice by two readers according to the Sharp/van der Heijde score, blinded to both treatment and true time sequence. Single-joint change scores in erosions were coupled with single joint swelling scores obtained from clinical examination. Consistency of observed improvement across readers and repeat reads was described, and factors expected to increase the likelihood of occurrence of both worsening and improvement of erosion were tested by GEE modelling.

Results: In every of the 4 independent reads, the mean change in erosion score was statistically significantly negative only in the subgroup of joints with absent or improved swelling, when erosions were present at baseline. Multivariate analysis showed that worsening of erosion score in a joint was significantly increased if that joint was already damaged at study entry, clinical swelling persisted, and methotrexate was used instead of etanercept. Repair was associated with improvement of swelling and use of etanercept (p≤0.007 for all associations).

Conclusion: Repair of erosions almost exclusively occurs in joints with improvement or absence of swelling, in patients treated with etanercept. Progression is seen more frequently in joints with persistent swelling, in patients receiving methotrexate monotherapy, primarily if damage is already present.

Statistics from Altmetric.com

Footnotes

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.